Cyanoguanidine compounds

12 3 Novel pyridyl cyanoguanidine compounds of general formula I (I) wherein R, X, Rand Rare as defined herein, exhibit a high antiproliferative activity and may be used in the treatment of hyperproliferative and neo-plastic diseases.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bjorkling, Fredrik, Dannacher, Heinz Wilhelm
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Bjorkling, Fredrik
Dannacher, Heinz Wilhelm
description 12 3 Novel pyridyl cyanoguanidine compounds of general formula I (I) wherein R, X, Rand Rare as defined herein, exhibit a high antiproliferative activity and may be used in the treatment of hyperproliferative and neo-plastic diseases.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08053446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08053446</sourcerecordid><originalsourceid>FETCH-uspatents_grants_080534463</originalsourceid><addsrcrecordid>eNrjZJBwrkzMy08vTczLTMnMS1VIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDCwNTYxMTMmAglAAM1I48</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cyanoguanidine compounds</title><source>USPTO Issued Patents</source><creator>Bjorkling, Fredrik ; Dannacher, Heinz Wilhelm</creator><creatorcontrib>Bjorkling, Fredrik ; Dannacher, Heinz Wilhelm ; Leo Pharma A/S</creatorcontrib><description>12 3 Novel pyridyl cyanoguanidine compounds of general formula I (I) wherein R, X, Rand Rare as defined herein, exhibit a high antiproliferative activity and may be used in the treatment of hyperproliferative and neo-plastic diseases.</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8053446$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8053446$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bjorkling, Fredrik</creatorcontrib><creatorcontrib>Dannacher, Heinz Wilhelm</creatorcontrib><creatorcontrib>Leo Pharma A/S</creatorcontrib><title>Cyanoguanidine compounds</title><description>12 3 Novel pyridyl cyanoguanidine compounds of general formula I (I) wherein R, X, Rand Rare as defined herein, exhibit a high antiproliferative activity and may be used in the treatment of hyperproliferative and neo-plastic diseases.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZJBwrkzMy08vTczLTMnMS1VIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDCwNTYxMTMmAglAAM1I48</recordid><startdate>20111108</startdate><enddate>20111108</enddate><creator>Bjorkling, Fredrik</creator><creator>Dannacher, Heinz Wilhelm</creator><scope>EFH</scope></search><sort><creationdate>20111108</creationdate><title>Cyanoguanidine compounds</title><author>Bjorkling, Fredrik ; Dannacher, Heinz Wilhelm</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_080534463</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bjorkling, Fredrik</creatorcontrib><creatorcontrib>Dannacher, Heinz Wilhelm</creatorcontrib><creatorcontrib>Leo Pharma A/S</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bjorkling, Fredrik</au><au>Dannacher, Heinz Wilhelm</au><aucorp>Leo Pharma A/S</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cyanoguanidine compounds</title><date>2011-11-08</date><risdate>2011</risdate><abstract>12 3 Novel pyridyl cyanoguanidine compounds of general formula I (I) wherein R, X, Rand Rare as defined herein, exhibit a high antiproliferative activity and may be used in the treatment of hyperproliferative and neo-plastic diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08053446
source USPTO Issued Patents
title Cyanoguanidine compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bjorkling,%20Fredrik&rft.aucorp=Leo%20Pharma%20A/S&rft.date=2011-11-08&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08053446%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true